Keel Point LLC Buys 176 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Keel Point LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.6% in the 4th quarter, HoldingsChannel reports. The firm owned 4,011 shares of the healthcare conglomerate’s stock after buying an additional 176 shares during the quarter. Keel Point LLC’s holdings in UnitedHealth Group were worth $2,112,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Wellington Management Group LLP raised its position in shares of UnitedHealth Group by 2.1% during the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock valued at $12,715,790,000 after buying an additional 527,526 shares during the last quarter. Morgan Stanley grew its holdings in shares of UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after purchasing an additional 1,893,192 shares during the last quarter. Moneta Group Investment Advisors LLC grew its holdings in UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after acquiring an additional 11,812,017 shares in the last quarter. Alliancebernstein L.P. raised its position in shares of UnitedHealth Group by 3.5% in the 2nd quarter. Alliancebernstein L.P. now owns 11,749,819 shares of the healthcare conglomerate’s stock valued at $5,647,433,000 after purchasing an additional 399,739 shares during the last quarter. Finally, Norges Bank purchased a new position in UnitedHealth Group during the 4th quarter worth approximately $5,210,004,000. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. TD Cowen dropped their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Morgan Stanley reduced their price objective on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a report on Friday, April 5th. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective for the company in a research report on Thursday, April 4th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $596.00 price target on shares of UnitedHealth Group in a report on Thursday, February 29th. Finally, Piper Sandler decreased their price objective on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a report on Wednesday, January 17th. Three investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $573.80.

Insider Buying and Selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

UnitedHealth Group Trading Up 1.7 %

Shares of UnitedHealth Group stock traded up $7.26 on Monday, reaching $446.46. 3,498,704 shares of the company were exchanged, compared to its average volume of 4,278,967. The stock has a fifty day moving average price of $492.29 and a 200-day moving average price of $516.34. The firm has a market capitalization of $411.60 billion, a price-to-earnings ratio of 18.74, a price-to-earnings-growth ratio of 1.20 and a beta of 0.54. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. The business had revenue of $94.43 billion for the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. UnitedHealth Group’s revenue for the quarter was up 14.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.34 earnings per share. On average, analysts expect that UnitedHealth Group Incorporated will post 27.7 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.68%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.54%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.